Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

NCT05367869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-05-24

No results posted yet for this study

Summary

Impact of Intraoperative Spraying methylene blue In thyroidectomy

Conditions

  • Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

Interventions

PROCEDURE

Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

General anaesthesia ,supine position with hyperextension to the neck Low collar incision to the neck , incision to the skin and platysma muscle and fascia ,upper and lower flaps are developed ,separation of strap muscles and identification of the thyroid gland after freeing of investing fascia Ligation of the middle thyroid vein and ligation and separation of the superior pedicle away from the external laryngeal nerve At this point of operation and before ligation of inferior pedicle methylene blue 0.05% spraying is applied to the field the amount varies according to size of the thyroid lobe and variation in population and neck size Thyroid gland stained by bluish color , recurrent laryngeal nerve not stained or minimally stained so we can avoid injury to it parathyroid glands get red of the stain after about 3 minutes so we can avoid injury to it thyroid gland lose its stain in about 15 minutes so we can remove any residual and decrease residual tissue or recurrence

Sponsors & Collaborators

  • Qena Oncology Center

    lead OTHER_GOV

Principal Investigators

  • Remon Elia Lukas, Specialist Surgical Oncology · Qena Oncology Center

  • Mohamed Taha Mousa, Resident Surgical Oncology · Qena Oncology Center

  • Mina Romany Tawfeek, Specialist General Surgery · Qena Oncology Center

  • Abdullah Atyah Ali, Ass.Lecture General Surgery · Qena Oncology Center--Luxor University

  • Ali Hassan, Resident General Surgery · Qena Oncology Center --Qena University

  • Mohamed Ahmed Orabi, Specialist Surgical Oncology · Qena Oncology Center

  • Amr M Makky, Specialist Surgical Oncology · Qena Oncology Center- Medical Military Academy

  • Mostafa Sayedd Abd el Rahaman, Resident Surgical Oncology · Qena Oncology Center

  • Mena Zarief Malaty, Resident General Surgery · Qena Oncology Center--Nag hammady Hospital

  • Hussein El Lithy, Resident General Surgery · Qena Oncology Center--Qena General Hospital

  • Abobakr Mohammed, Resident General Surgery · Qena Oncology Center--Qena General Hospital

  • Mohamed Mahmoud El Zeer, Resident General Surgery · Qena Oncology Center- Sohag University

  • Mahmoud Rabeea Ahmed, Resident General Surgery · Qena Oncology Center-Aswan University

  • Mohamed Abouelmagd Salem, Prof. Surgical Oncology · Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University

  • Mohamed Saeed Ayaty, Ass.Prof. Surgical Oncology · Qena Oncology Center-National Cancer Institute Cairo University

  • Mohamed H Mahran, Ass.Prof. Surgical Oncology · Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University

  • Mohamed Hasan Abdel-Aal, Director of QOC · Qena Oncology Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-05-31
Completion
2023-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367869 on ClinicalTrials.gov